Characterization of the aldolase B intronic enhancer

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Aldolase B is crucial for fructose metabolism and is highly expressed in the liver, kidney, and small intestine.
• High-level aldolase B gene expression is driven by a liver-specific promoter and an intronic enhancer.
• Understanding aldolase B gene regulation is vital for metabolic research.

Purpose of the Study:

• To identify and characterize the liver-specific enhancer of the aldolase B gene.
• To determine the functional domains and transcription factor binding sites within the aldolase B enhancer.
• To elucidate the roles of specific transcription factors in regulating aldolase B expression.

Main Methods:

• Deletional analysis to map the aldolase B enhancer region.
• Transient transfection assays using Hep G2 hepatoma cells.
• Electrophoretic mobility shift assays (EMSA) to identify transcription factor binding.
• Site-directed mutagenesis to assess the functional impact of binding sites.

Main Results:

• A 400-bp fragment in the first intron functions as a potent, liver-specific enhancer.
• The enhancer comprises two domains (Ba and Bb) that synergize for maximal activity.
• Hepatic nuclear factor 1 (HNF1) and hepatic nuclear factor 4 (HNF4) binding sites were identified within the Bb domain.
• Mutation of HNF1 binding sites abolished enhancer activity, while HNF4 site mutation reduced it by 80%.

Conclusions:

• The aldolase B enhancer activity is critically dependent on HNF1 and HNF4 transcription factors.
• These findings provide insights into the molecular mechanisms of liver-specific gene regulation.
• The identified enhancer and its regulatory elements offer tools for studying aldolase B function and liver biology.